August 16, 2025

From sex hormone decrease to hormonal treatment: impacts on cardiovascular risk with ageing.

View Full Paper

Ask AI

Bookmark

Cardiovascular risk increases with ageing, highlighting the importance of monitoring sex hormone levels and treatments.
Key evidence from the Women Health Initiative revealed increased cardiovascular events in women over 70 using certain hormone treatments.
Analysis of clinical outcomes is based on both estrogens and androgens to understand their protective effects against cardiovascular disease.
The significance of optimal hormone doses in treatment remains unclear, indicating the need for careful consideration in clinical interventions.

Discussion

No takes yet. Share an insight, caveat, or question.

Observational analysis shows cardiovascular risk rises with ageing in both sexes, suggesting hormone therapy may help mitigate it.

Fontaine et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark